Molgramostim
Showing 126 - 135 of 135
Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Houston (DTGM)
Terminated
- Acute Myelogenous Leukemia
- Chronic Myelomonocytic Leukemia
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Feb 20, 2012
Lymphoma Trial in Houston (Campath-1H, G-CSF, GM-CSF)
Melanoma Trial in New York (GM-CSF DNA, NSC 683472 gp100: 209-217(210M), NSC 699048 Tyrosinase: 368-376(370D))
Completed
- Melanoma
- GM-CSF DNA, NSC 683472 gp100: 209-217(210M), NSC 699048 Tyrosinase: 368-376(370D)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 9, 2011
Metastatic Cancer, Sarcoma Trial (biological, drug, other, procedure, radiation)
Completed
- Metastatic Cancer
- Sarcoma
- aerosol sargramostim
- +14 more
- (no location specified)
May 13, 2011
Pulmonary Alveolar Proteinosis Trial in Pavia (GM-CSF [Leukine (Sargramostim)], WLL)
Unknown status
- Pulmonary Alveolar Proteinosis
- GM-CSF [Leukine (Sargramostim)]
- WLL
-
Pavia, PV, ItalyFondazione IRCCS Policlinico San Matteo
Jul 27, 2009
Acute Myeloid Leukemia Trial in Tours (Active comparator (no fludarabine), Experimental (fludarabine))
Completed
- Acute Myeloid Leukemia
- Active comparator (no fludarabine)
- Experimental (fludarabine)
-
Tours, FranceGOELAMS
Jun 19, 2009
Burkitt Lymphoma, Lymphoma, Large-Cell, Diffuse, Lymphoma, Small Noncleaved-Cell Trial run by the NCI (granulocyte-macrophage
Completed
- Burkitt Lymphoma
- +2 more
- granulocyte-macrophage colony stimulating factor (GM-CSF)
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Malignant Melanoma Trial in San Francisco (Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF))
Completed
- Malignant Melanoma
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
-
San Francisco, CaliforniaNorthern California Melanoma Center
Jul 10, 2006